Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
McGregor M, Esfandiari S
Record ID 32010000177
English
Authors' recommendations:
In spite of a high mortality risk, and uncertain long‐term prognosis, transcatheter aortic valve implantation is a feasible procedure that clearly gives survivors symptomatic relief and probably causes some overall extension of life . It can be carried out at the MUHC at a net cost of approximately $24,024 per patient. The budget impact of the anticipated 30 patients per year would be approximately $720,719
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/files/tau/TAVI_REPORT.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Heart Valve Prosthesis
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, 536-5100 Boul. Maisonneuve O, Montreal, H4A 3T2
Contact Name:
eva.suarthana@mcgill.ca
Contact Email:
nisha.almeida@muhc.mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.